Fox13, February 9, 2022: President Joe Biden’s pick to lead the Food and Drug Administration has stalled in the narrowly divided Senate, an unexpected setback that could delay decisions on electronic cigarettes and other high-profile health issues. Will all the publicity help Califf get confirmed, given the alternatives?
Read More »Press Releases
Statement of Dr. Diana Zuckerman on FDA’s Approval of Alzheimer’s Drug Aduhelm
June 8, 2021: Dr. Diana Zuckerman, president of NCHR, speaks out against FDA’s approval of the ineffective Alzheimer’s drug aduhelm.
Read More »Dr. Diana Zuckerman’s Statement on FDA’s Draft Guidance on Labeling for Breast Implants
October 23, 2019. The FDA’s draft includes the types of information that we have proposed to the FDA in recent months in our work with patient advocates and plastic surgeons. The devil is in the details, so we look forward to working with the FDA to finalize these materials so that patients can make better informed decisions in the future than most women considering breast implants have been able to make.
Read More »NCHR Letter Concerning Lead in DC Public School Playground
After lead was found in the playground at Janney Elementary School in Washington, DC, NCHR wrote a letter to DC Education Officials.
Read More »2019 Foremother and Health Policy Hero Awards Luncheon Invitation
Join us for our annual Awards Luncheon where we honor Foremothers who have broken down barriers and health policy heroes.
Read More »